GSK Shingrix Shingles Vaccine from United States
Shingrix is a recombinant zoster vaccine containing glycoprotein E antigen and AS01B adjuvant to prevent herpes zoster. It is packaged in measured doses for retail sale, fitting tariff item 3002.15.00 as an immunological product.
Duty Rate — United States → Canada
0%
Import Tips
• Confirm the vaccine has a Health Canada licence before import
• Provide the CBSA with the product's composition and retail packaging details to support classification
• Store the vaccine at the recommended temperature and document the cold chain